Combining acupoint stimulation with oxycodone for pain relief after gynecologic surgery
Effect of Transcutaneous Electrical Acupoint Stimulation Combined With Oxycodone on Postoperative Visceral Pain and Early Recovery Quality in Gynecologic Laparoscopic Patients
This study is testing if using electrical acupoint stimulation along with oxycodone can help relieve pain better for adults recovering from gynecologic laparoscopic surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Yangzhou University Academic / other |
| Locations | 1 site (Yangzhou, Jiangsu) |
| Trial ID | NCT06517069 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness and feasibility of transcutaneous electrical acupoint stimulation (TEAS) combined with oxycodone for managing postoperative visceral pain in patients undergoing gynecologic laparoscopic surgeries. It aims to optimize pain management strategies in this patient population by evaluating pain relief outcomes. Eligible participants include adults aged 18-65 with a specific BMI and ASA grade, while those with certain medical conditions or drug allergies are excluded. The study will take place at the Affiliated Hospital of Yangzhou University from May to July 2024.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with a BMI of 18.5-30 and ASA grade I or II who are scheduled for gynecologic laparoscopic surgery.
Not a fit: Patients with allergies to the study drugs, cognitive impairments, or certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve postoperative pain management for patients undergoing gynecologic laparoscopic procedures.
How similar studies have performed: While the combination of TEAS and opioids is a novel approach, similar studies have shown promise in enhancing pain management, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-65 years * American Society of Anesthesiologists grade I-II * Body mass index (BMI) 18.5-30 kg/m2; * No ulceration or infection at the acupuncture stimulation site. Exclusion Criteria: * Allergic to the drugs used in the study; * People with unclear consciousness or cognitive dysfunction; * There are contraindications of percutaneous acupoint electrical stimulation; * Abnormal cardiopulmonary and liver and kidney function; * History of analgesic drug use within one week; * History of diabetes, myocardial infarction or cerebrovascular accident.
Where this trial is running
Yangzhou, Jiangsu
- Affiliated Hospital of Yangzhou University — Yangzhou, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Meiyu Liu
- Email: myliu@yzu.edu
- Phone: +86 177 6198 0727
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.